MedDataX Logo

Early NCPAP Before Surfactant Treatment in Very Preterm Infants With RDS

NCT ID: NCT01996670

Last Updated: 2013-11-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

683 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

We hypothesis a period of early NCPAP before surfactant treatment is effective for treating RDS and preventing BPD in very premature infants.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Surfactant Versus Nasal Continuous Positive Airway Pressure (nCPAP) for Respiratory Distress Syndrome in the Newborn ≥ 35 Weeks of Gestation

NCT01306240

Acute Respiratory Distress Syndrome
TERMINATED PHASE3

Optimal Dose of Surfactant for Preterm Infants With Respiratory Distress Syndrome

NCT04984057

Respiratory Distress Syndrome, Newborn Patent Ductus Arteriosus Bronchopulmonary Dysplasia +1 more
UNKNOWN NA

Sustained Lung Inflation With CPAP in Preterm Neonates (SI-CPAP)

NCT03916523

RDS of Prematurity
COMPLETED NA

Early Surfactant Administration at FiO₂ >0.25 Under NIPPV for RDS in Very Preterm Infants

NCT07100652

Respiratory Distress Syndrome (&Amp; [Hyaline Membrane Disease])
NOT_YET_RECRUITING NA

Impact of Delayed Cord Clamping and Minimally Invasive Surfactant Administration on Outcomes in Premature Infants Less Than 30 Weeks Gestation

NCT07092319

NRDS
NOT_YET_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Nasal Continuous Positive Airway Pressure, Preterm Infants, Surfactant Treatment, Respiratory Distress Syndrome, Bronchopulmonary Dysplasia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

<2h group

No interventions assigned to this group

2-4h group

No interventions assigned to this group

>4h group

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All enrolled infants were able to breathe at 5 min of age, had evidence of respiratory distress, unable to receive surfactant therapy, and were administrated with early NCPAP as the initial treatment
Minimum Eligible Age

30 Minutes

Maximum Eligible Age

2 Hours

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Xiangya Hospital of Central South University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Huiyi Huo

Department of Neonatology

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

huo20131121

Identifier Type: REGISTRY

Identifier Source: secondary_id

huohuiyi20131121

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Surfactant for Neonatal Respiratory Distress Syndrome(NRDS) and Neonatal Acute Respiratory Distress Syndrome(NARDS)
NCT04777760 RECRUITING
Minimally Invasive Surfactant Therapy Followed by CPAP (MISTCPAP) in Preterm Infants With RDS
NCT01723683 UNKNOWN PHASE2
Comparison of Two Different NCPAP Methods in Preterm Infants With Respiratory Distress Syndrome
NCT03400670 UNKNOWN NA
Predictors for Nasal Intermittent Positive Pressure Ventilation Failure for Premature Infants With Respiratory Distress Syndrome
NCT05260424 COMPLETED
Very Early Surfactant and NCPAP for Premature Infants With RDS
NCT00563641 COMPLETED PHASE3
Nasal Intermittent Positive Pressure Ventilation(NIPPV) vs Continuous Positive Airway Pressure for Respiratory Distress Syndrome
NCT03226977 UNKNOWN NA
"Effectiveness of Delivery Room Bubble CPAP in Preterm Infants With Respiratory Distress
NCT07162285 ENROLLING_BY_INVITATION NA
The Effect of Surfactant Dose on Outcomes in Preterm Infants With RDS
NCT03808402 COMPLETED
Cpap at Delivery Room for Preterm Infants
NCT01024361 UNKNOWN PHASE4
Early Surfactant to Reduce Use of Mechanical Breathing in Low Birth Weight Infants
NCT00005774 TERMINATED PHASE3
Effect of High Flow Nasal Cannula Versus Nasal Continuous Positive Airway Pressure
NCT05849116 UNKNOWN
Clinical RD (Respiratory Distress) Score for Objective Decision Making for Surfactant Therapy
NCT03273764 COMPLETED
Immediate Treatment Outcomes of b-CPAP vs Oxygen Therapy in Preterm Babies Presenting With RDS at KCMC
NCT03620448 COMPLETED NA
Surfactant Using a Supraglottic Airway Device in Late Preterm to Early Term Infants
NCT07176117 NOT_YET_RECRUITING NA
Does The Surfactant Administration by Aerosolization Effective?
NCT02825953 UNKNOWN NA
Surfactant for Neonatal Respiratory Distress Syndrome at High Altitude Areas:a Prospective Cohort Study
NCT03479450 UNKNOWN
Optimal High CPAP Pressures in Preterm Neonates Post-extubation
NCT05230485 UNKNOWN NA
NHFOV vs. NCPAP as a Primary Treatment to Neonatal Respiratory Distress Syndrome(NRDS)
NCT03099694 COMPLETED NA
Comparison of Continuous Positive Airway Pressure (CPAP) and Non-Invasive Positive Pressure Ventilation (NIPPV) in Preterm Newborns With Respiratory Distress Syndrome.
NCT06966752 RECRUITING NA
Optimising Breathing Support at Extubation in Very Preterm Infants: A Clinical Study
NCT07251790 NOT_YET_RECRUITING NA
Effect of Nasal CPAP Versus NIPPV On Diaphragm Electrical Activity (Edi) In VLBW Preterm Infants
NCT06295484 RECRUITING NA
To Investigate the Effect of Pulmonary Surfactant With Different Inspired Oxygen Concentrations on the Clinical Outcomes of Very Preterm Infants Under Non-invasive Assisted Ventilation
NCT07235345 ENROLLING_BY_INVITATION NA
Modified Intubation-surfactant-extubation (InSurE) Technique in Preterm Neonates With Respiratory Distress Syndrome
NCT03989960 UNKNOWN NA
Application of Lung Near-Infrared Spectroscopy (NIRS) in Preterm Infants
NCT05961670 UNKNOWN
Will CPAP Reduce Length Of Respiratory Support In Premature Infants?
NCT00486395 TERMINATED PHASE3